Publication: Should One Use the Combination of Abiraterone and Poly(ADP-Ribose) Polymerase Inhibitors as First-Line Therapy for All Patients With Metastatic Castration-Resistant Prostate Cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Gumusay, Ozge/0000-0002-6236-9829;
Citation
WoS Q
Q3
Scopus Q
Q3
Source
Future Oncology
Volume
18
Issue
39
Start Page
4235
End Page
4238